DHG Pharmaceutical JSC (VN:DHG) — Market Cap & Net Worth
Market Cap & Net Worth: DHG Pharmaceutical JSC (DHG)
DHG Pharmaceutical JSC (VN:DHG) has a market capitalization of $496.76 Million (₫13.07 Trillion) as of May 4, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #12579 globally and #62 in its home market, demonstrating a 0.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DHG Pharmaceutical JSC's stock price ₫100000.00 by its total outstanding shares 130746071 (130.75 Million). Analyse cash flow conversion of DHG Pharmaceutical JSC to see how efficiently the company converts income to cash.
DHG Pharmaceutical JSC Market Cap History: 2015 to 2026
DHG Pharmaceutical JSC's market capitalization history from 2015 to 2026. Data shows growth from $157.41 Million to $496.76 Million (11.29% CAGR).
DHG Pharmaceutical JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DHG Pharmaceutical JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
DHG Pharmaceutical JSC's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
DHG Pharmaceutical JSC's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $368.23 Million | $3.90 Trillion | $635.39 Billion | 0.00x | 0.00x |
| 2020 | $436.69 Million | $3.76 Trillion | $739.87 Billion | 0.00x | 0.00x |
| 2021 | $493.75 Million | $4.00 Trillion | $777.22 Billion | 0.00x | 0.00x |
| 2022 | $383.02 Million | $4.68 Trillion | $988.45 Billion | 0.00x | 0.00x |
| 2023 | $484.06 Million | $5.02 Trillion | $1.05 Trillion | 0.00x | 0.00x |
| 2024 | $516.13 Million | $4.88 Trillion | $778.92 Billion | 0.00x | 0.00x |
| 2025 | $508.18 Million | $5.27 Trillion | $897.58 Billion | 0.00x | 0.00x |
Competitor Companies of DHG by Market Capitalization
Companies near DHG Pharmaceutical JSC in the global market cap rankings as of May 4, 2026.
Key companies related to DHG Pharmaceutical JSC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
DHG Pharmaceutical JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, DHG Pharmaceutical JSC's market cap moved from $157.41 Million to $ 496.76 Million, with a yearly change of 11.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫496.76 Million | -2.25% |
| 2025 | ₫508.18 Million | -1.54% |
| 2024 | ₫516.13 Million | +6.62% |
| 2023 | ₫484.06 Million | +26.38% |
| 2022 | ₫383.02 Million | -22.43% |
| 2021 | ₫493.75 Million | +13.07% |
| 2020 | ₫436.69 Million | +18.59% |
| 2019 | ₫368.23 Million | +18.37% |
| 2018 | ₫311.08 Million | -30.30% |
| 2017 | ₫446.31 Million | +84.48% |
| 2016 | ₫241.93 Million | +53.70% |
| 2015 | ₫157.41 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of DHG Pharmaceutical JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $496.76 Million USD |
| MoneyControl | $496.76 Million USD |
| MarketWatch | $496.76 Million USD |
| marketcap.company | $496.76 Million USD |
| Reuters | $496.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures a… Read more